Industry Notes

Market Perspective

U.S. Biotech Stocks Up 60% in July 2025: What’s Behind the Surge and What Risks Remain

Market Perspective

Q1 2025 Snapshot: Biopharma financing is consolidating

Decision-making

Importance of focus in the CEO’s decision making

Investments | Policy

Policy uncertainty drives capital investments down

Market Perspective

Sidelining small molecules: Economic hypotheses

Behavioral Analysis | Startups

Assessing human capital of founding teams before investment